These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30601068)

  • 21. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
    Narang AS; Chang RK; Hussain MA
    J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biophysics and Thermodynamics: The Scientific Building Blocks of Bio-inspired Drug Delivery Nano Systems.
    Demetzos C
    AAPS PharmSciTech; 2015 Jun; 16(3):491-5. PubMed ID: 25899798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanocrystal technology in the delivery of poorly soluble drugs: an overview.
    Nagarwal RC; Kumar R; Dhanawat M; Das N; Pandit JK
    Curr Drug Deliv; 2011 Jul; 8(4):398-406. PubMed ID: 21453258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineering Carbohydrate-Based Particles for Biomedical Applications: Strategies to Construct and Modify.
    Thodikayil AT; Sharma S; Saha S
    ACS Appl Bio Mater; 2021 Apr; 4(4):2907-2940. PubMed ID: 35014384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
    Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
    Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unique benefits of nanotechnology to drug delivery and diagnostics.
    McNeil SE
    Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combining Nanoparticle Shape Modulation and Polymersome Technology in Drug Delivery.
    Katterman C; Pierce C; Larsen J
    ACS Appl Bio Mater; 2021 Apr; 4(4):2853-2862. PubMed ID: 35014381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal-nanotechnology: revolution for efficient therapeutics delivery.
    Kumar A; Pandey AN; Jain SK
    Drug Deliv; 2016; 23(3):681-93. PubMed ID: 24901207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Core-shell supramolecular gelatin nanoparticles for adaptive and "on-demand" antibiotic delivery.
    Li LL; Xu JH; Qi GB; Zhao X; Yu F; Wang H
    ACS Nano; 2014 May; 8(5):4975-83. PubMed ID: 24716550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel.
    Liu Y; Li K; Pan J; Liu B; Feng SS
    Biomaterials; 2010 Jan; 31(2):330-8. PubMed ID: 19783040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.
    Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M
    Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticles for ocular drug delivery: modified and non-modified chitosan as a promising biocompatible carrier.
    Pontillo ARN; Detsi A
    Nanomedicine (Lond); 2019 Jul; 14(14):1889-1909. PubMed ID: 31274373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nano-drug delivery systems in wound treatment and skin regeneration.
    Wang W; Lu KJ; Yu CH; Huang QL; Du YZ
    J Nanobiotechnology; 2019 Jul; 17(1):82. PubMed ID: 31291960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoparticles in drug delivery and environmental exposure: same size, same risks?
    Borm PJ; Müller-Schulte D
    Nanomedicine (Lond); 2006 Aug; 1(2):235-49. PubMed ID: 17716113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery.
    Chavanpatil MD; Khdair A; Panyam J
    J Nanosci Nanotechnol; 2006; 6(9-10):2651-63. PubMed ID: 17048473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of biomimetism in developing nanostructured inorganic matrices for drug delivery.
    Roveri N; Palazzo B; Iafisco M
    Expert Opin Drug Deliv; 2008 Aug; 5(8):861-77. PubMed ID: 18712996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent trends of nanomedicinal approaches in clinics.
    Dilnawaz F; Acharya S; Sahoo SK
    Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chitosan nanoparticles: a promising system in novel drug delivery.
    Nagpal K; Singh SK; Mishra DN
    Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1423-30. PubMed ID: 21048331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances of calcium phosphate nanoparticles for controlled drug delivery.
    Jun W; Lin L; Yurong C; Juming Y
    Mini Rev Med Chem; 2013 Aug; 13(10):1501-7. PubMed ID: 22697516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.